Thero2-01S22
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Thero2-01S22, covering 2023-01-26 to 2023-01-26. Get the full timeline:
Most recent: Clinical Trial Update: Thero2-01S22 in HER2-positive Breast Cancer [Phase 3]